Effect of uterine artery embolization used in treatment of adenomyosis on ovarian funtion
article
OA: closed
CC0
AI-generated summary
This study found that uterine artery embolization for adenomyosis significantly reduced uterine volume and altered uterine artery hemodynamics while largely preserving ovarian function, though one patient experienced transient ovarian failure.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective:To investigate the effects on ovarian function of uterine artery embolization (UAE) for the treatment of adenomyosis and complications of UAE.Methods:UAE was performed in 27 cases with adenomyosis, and the embolic agent was polyvinyl alcohol particles (PVA).The effects of the treatment, levels of sexual hormone were evaluated, and the uterus artery and ovarian artery were examined with transvaginal Color Doppler Energy Sonography (TVCDES) before UAE and the 1st day, 3 months, 6 months after UAE.Results:After 3 months of UAE, the volume of uterus was decreased dramatically by 136.48 cm3(37.6%), Vmax (cm/s) of uterine artery was lower, from(27.27±6.03)cm/s to (14.19±5.98)cm/s,P0.05, RI of uterine artery was increased, form 0.54±0.03 to 0.86±0.04,P0.05; There was no difference in ovarian blood stream, FSH, E2 and menstrual cycle after UAE; One patient had short phase of ovarian function reduction dramatically. Conclusion:UAE for adenomyosis is a new,less-trauma,safe,effective,less-complications and short-time recovery therapy with satisfying midterm effects, which can preserve uterine function and do not damage the function of ovaries,but it may cause ovarian failure.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK